아처-데니얼스-미들랜드 분석가 평가

We need to translate to Korean, preserving numbers, percentages, dates, ticker symbols ($ADM), and well-known acronyms (AI, ETF, EPS). Also keep proper nouns in conventional target-language form (company names, person names). The marker must remain untouched at the end.

We must output only the translated description, in Hangul, no romanization, no echo of English.

We need to translate the three sections: What happened, Market impact, What to watch next.

We must keep numbers, percentages, dates, ticker symbols ($ADM) unchanged. Also keep acronyms like EPS, P/E, RSI, IPO, ETF, EBITDA, ROE as-is (but none appear). Also keep "UBS" as is? It's an acronym, likely keep as is. "ADM" is ticker symbol, keep as is. "Jeff Rowe" person name: keep as is? Proper nouns should be kept in conventional target-language form. Person names usually not translated, keep as is. Company names: Archer-Daniels-Midland (ADM) - keep as is? Probably keep the English name, but could translate? The rule: Keep proper nouns (company names, person names) in their conventional target-language form. In Korean, company names are often kept in original English or transliterated? Usually they'd name. For foreign companies, they often keep the English name or sometimes translate. The rule says keep them in conventional target-language form. For Archer-Daniels-Midland, the conventional Korean form is "아처 다니엘스 미들랜드"? Actually Korean media often keep the English name "Archer-Daniels-Midland" or sometimes "아처 다니엘스 미들랜드". But I think they keep the English name. However, to be safe, we can keep the English name as is, as it's a proper noun. The rule says keep proper nouns in their conventional target-language form. If the conventional form is English, keep English. So we keep "Archer-Daniels-Midland". Also "UBS" keep as is. "Jeff Rowe" keep as is.

We need to translate the rest into Korean, formal analytical style like 한국경제, 매일경제.

We must preserve the marker at end exactly:

We must output only the translated description, no extra commentary.

Let's translate.

Original:

What happened: UBS analysts raised their price targets for Archer-Daniels-Midland (ADM) twice in recent months, from $70 to $90 in May, then to $95 in June. ADM was also highlighted in two bullish reports: "12 Stocks From Companies Generating High Cash Flow" and "11 Best Rising Dividend Stocks to Buy Right Now". Meanwhile, ADM appointed Jeff Rowe as Executive Vice President and Chief Operating Officer, effective August 17.

Market impact: The price target increases